Congress is preparing to vote on a series of tough-on-China bills next month, with a focus on comprehensive legislative packages aimed at addressing various issues related to China. According to Michael Pillsbury, these legislative efforts are gaining traction and are expected to include measures concerning the de minimis trade threshold and outbound investments. The House leadership is reportedly looking at late September for the vote, indicating a growing urgency to address concerns surrounding China, particularly in the biopharma sector where anti-China legislation is beginning to have an impact.